Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anti-apoptotic protein expression refers to the cellular production of proteins that inhibit apoptosis, the programmed cell death process. These proteins, primarily from the BCL-2 family (BCL-2, BCL-XL, MCL-1, A1/BFL-1, BCL-W), are crucial for cell survival by blocking pro-apoptotic signals and pathways, preventing mitochondrial outer membrane permeabilization (MOMP), and inhibiting caspase activation. Dysregulation or overexpression is implicated in cancer and drug resistance, making them important therapeutic targets.
Inhibition of pro-apoptotic proteins (BAX, BAK, BIM, PUMA), prevention of mitochondrial outer membrane permeabilization (MOMP), and blocking caspase activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-Apoptotic Protein Expression.